A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations

FASEB Journal

Volumn 20, Issue 11, 2006, Pages

  Irvine, Katharine M ^a   Burns, Christopher J ^b   Wilks, Andrew F ^b   Su, Stephen ^b   Hume, David A ^a   Sweet, Matthew J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

BMM; fms; Imatinib mesylate; Inflammation; TEPM

Indexed keywords

ABELSON KINASE; APOLIPOPROTEIN E; COLONY STIMULATING FACTOR 1; CYC 10268; CYTOKINE; IMATINIB; LIPOPOLYSACCHARIDE; PHOSPHOTRANSFERASE INHIBITOR; THIOGLYCOLIC ACID; TOLL LIKE RECEPTOR 9; UROKINASE; CHIMERIC PROTEIN; COLONY STIMULATING FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL CULTURE; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY; PLASMID;

MURINAE;

ANIMALS; CELL LINE; CELL SURVIVAL; CLONING, MOLECULAR; CYTOKINES; HUMANS; INFLAMMATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MUTANT CHIMERIC PROTEINS; PLASMIDS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; TRANSFECTION;

EID: 33845581266     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-5848fje     Document Type: Article

References (82)

1. Tushinski, R. J., Oliver, I. T., Guilbert, L. J., Tynan, P. W., Warner, J. R., and Stanley, E. R. (1982) Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28, 71-81
2. Cecchini, M. G., Dominguez, M. G., Mocci, S., Wetterwald, A., Felix, R., Fleisch, H., Chisholm, O., Hofstetter, W., Pollard, J. W., and Stanley, E. R. (1994) Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120, 1357-1372
3. Stanley, E. R., Berg, K. L., Einstein, D. B., Lee, P. S., Pixley, F. J., Wang, Y., and Yeung, Y. G. (1997) Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46, 4-10
4. Hume, D. A., Pavli, P., Donahue, R. E., and Fidler, I. J. (1988) The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. J. Immunol. 141, 3405-3409
5. Dai, X. M., Ryan, G. R., Hapel, A. J., Dominguez, M. G., Russell, R. G., Kapp, S., Sylvestre, V., and Stanley, E. R. (2002) Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99, 111-120
6. Sherr, C. J., Rettenmier, C. W., Sacca, R., Roussel, M. F., Look, A. T., and Stanley, E. R. (1985) The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41, 665-676
7. Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A. W., Jr., Ahmed-Ansari, A., Sell, K. W., Pollard, J. W., and Stanley, E. R. (1990) Total absence of colony-stimulating factor 1 in the macrophagedeficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. U. S. A. 87, 4828-4832
8. Hubbard, S. R., and Till, J. H. (2000) Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69, 373-398
9. Sevilla, L., Zaldumbide, A., Carlotti, F., Dayem, M. A., Pognonec, P., and Boulukos, K. E. (2001) Bcl-XL expression correlates with primary macrophage differentiation, activation of functional competence, and survival and results from synergistic transcriptional activation by Ets2 and PU. 1. J. Biol. Chem. 276, 17800-17807
10. Dey, A., She, H., Kim, L., Boruch, A., Guris, D. L., Carlberg, K., Sebti, S. M., Woodley, D. T., Imamoto, A., and Li, W. (2000) Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol. Biol. Cell. 11, 3835-3848
11. Sherr, C. J., Matsushime, H., and Roussel, M. F. (1992) Regulation of CYL/cyclin D genes by colony-stimulating factor 1. Ciba Found Symp. 170, 209-219
12. Guidez, F., Li, A. C., Horvai, A., Welch, J. S., and Glass, C. K. (1998) Differential utilization of Ras signaling pathways by macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF receptors during macrophage differentiation. Mol. Cell. Biol. 18, 3851-3861
13. Stacey, K. J., Fowles, L. F., Colman, M. S., Ostrowski, M. C., and Hume, D. A. (1995) Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Mol. Cell. Biol. 15, 3430-3441
14. Chapoval, A. I., Kamdar, S. J., Kremlev, S. G., and Evans, R. (1998) CSF-1 (M-CSF) differentially sensitizes mononuclear phagocyte subpopulations to endotoxin in vivo: a potential pathway that regulates the severity of gram-negative infections. J. Leukoc. Biol. 63, 245-252
15. Evans, R., Kamdar, S. J., Duffy, T. M., and Fuller, J. (1992) Synergistic interaction of bacterial lipopolysaccharide and the monocyte-macrophage colony-stimulating factor: potential quantitative and qualitative changes in macrophage-produced cytokine bioactivity. J. Leukoc. Biol. 51, 93-96
16. Sweet, M. J., Campbell, C. C., Sester, D. P., Xu, D., McDonald, R. C., Stacey, K. J., Hume, D. A., and Liew, F. Y. (2002) Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. J. Immunol. 168, 392-399
17. Moss, S. T., and Hamilton, J. A. (2000) Proliferation of a subpopulation of human peripheral blood monocytes in the presence of colony stimulating factors may contribute to the inflammatory process in diseases such as rheumatoid arthritis. Immunobiology 202, 18-25
18. Sweet, M. J., and Hume, D. A. (2003) CSF-1 as a regulator of macrophage activation and immune responses. Arch. Immunol. Ther. Exp. (Warszaw) 51, 169-177
19. Hamilton, J. A. (2003) Nondisposable materials, chronic inflammation, and adjuvant action. J. Leukoc. Biol. 73, 702-712
20. Campbell, I. K., Rich, M. J., Bischof, R. J., and Hamilton, J. A. (2000) The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukoc. Biol. 68, 144-150
21. Bischof, R. J., Zafiropoulos, D., Hamilton, J. A., and Campbell, I. K. (2000) Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. Clin. Exp. Immunol. 119, 361-367
22. Sapi, E., and Kacinski, B. M. (1999) The role of CSF-1 in normal and neoplastic breast physiology. Proc. Soc. Exp. Biol. Med. 220, 1-8
23. Kacinski, B. M. (1997) CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol. Reprod. Dev. 46, 71-74
24. Toy, E. P., Chambers, J. T., Kacinski, B. M., Flick, M. B., and Chambers, S. K. (2001) The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma. Gynecol. Oncol. 80, 194-200
25. Lin, E. Y., Nguyen, A. V., Russell, R. G., and Pollard, J. W. (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740
26. Yee, L. D., and Liu, L. (2000) The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells. Anticancer Res. 20, 4379-4383
27. Chambers, S. K., Wang, Y., Gertz, R. E., and Kacinski, B. M. (1995) Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res. 55, 1578-1585
28. Lin, E. Y., Gouon-Evans, V., Nguyen, A. V., and Pollard, J. W. (2002) The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J. Mammary Gland Biol. Neoplasia 7, 147-162
29. Aharinejad, S., Paulus, P., Sioud, M., Hofmann, M., Zins, K., Schafer, R., Stanley, E. R., and Abraham, D. (2004) Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res. 64, 5378-5384
30. Aharinejad, S., Abraham, D., Paulus, P., Abri, H., Hofmann, M., Grossschmidt, K., Schafer, R., Stanley, E. R., and Hofbauer, R. (2002) Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res. 62, 5317-5324
31. Okazaki, T., Ebihara, S., Takahashi, H., Asada, M., Kanda, A., and Sasaki, H. (2005) Macrophage colony-stimulating factor induces vascular endothelial growth factor production in skeletal muscle and promotes tumor angiogenesis. J. Immunol. 174, 7531-7538
32. Dewar, A. L., Cambareri, A. C., Zannettino, A. C., Miller, B. L., Doherty, K. V., Hughes, T. P., and Lyons, A. B. (2005) Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 105, 3127-3132
33. Taylor, J. R., Brownlow, N., Domin, J., and Dibb, N. J. (2006) FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance. Oncogene 25, 147-151
34. Murray, L. J., Abrams, T. J., Long, K. R., Ngai, T. J., Olson, L. M., Hong, W., Keast, P. K., Brassard, J. A., O'Farrell, A. M., Cherrington, J. M., and Pryer, N. K. (2003) SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model. Clin. Exp. Metastasis 20, 757-766
35. Conway, J. G., McDonald, B., Parham, J., Keith, B., Rusnak, D. W., Shaw, E., Jansen, M., Lin, P., Payne, A., Crosby, R. M., et al. (2005) Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc. Natl. Acad. Sci. U. S. A. 102, 16078-16083
36. Burns, C. J., Bu, X. Y., and Wilks, A. F. (2003) Substitute pyrazines useful as kinase inhibitors. WO 03099796
37. Sester, D. P., Beasley, S. J., Sweet, M. J., Fowles, L. F., Cronau, S. L., Stacey, K. J., and Hume, D. A. (1999) Bacterial/CpG DNA down-modulates colony stimulating factor-1 receptor surface expression on murine bone marrow-derived macrophages with concomitant growth arrest and factor-independent survival. J. Immunol. 163, 6541-6550
38. Sudo, T., Nishikawa, S., Ogawa, M., Kataoka, H., Ohno, N., Izawa, A., and Hayashi, S. (1995) Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 11, 2469-2476
39. Fabbro, D., Ruetz, S., Buchdunger, E., Cowan-Jacob, S. W., Fendrich, G., Liebetanz, J., Mestan, J., O'Reilly, T., Traxler, P., Chaudhuri, B., et al. (2002) Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacol. Ther. 93, 79-98
40. Seggewiss, R., Lore, K., Greiner, E., Magnusson, M. K., Price, D. A., Douek, D. C., Dunbar, C. E., and Wiestner, A. (2005) Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner. Blood 105, 2473-2479
41. Dosil, M., Wang, S., and Lemischka, I. R. (1993) Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells. Mol. Cell. Biol. 13, 6572-6585
42. Williams, G. T., Smith, C. A., Spooncer, E., Dexter, T. M., and Taylor, D. R. (1990) Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343, 76-79
43. Goyal, A., Wang, Y., Graham, M. M., Doseff, A. I., Bhatt, N. Y., and Marsh, C. B. (2002) Monocyte survival factors induce Akt activation and suppress caspase-3. Am. J. Respir. Cell Mol. Biol. 26, 224-230
44. Okada, S., Zhang, H., Hatano, M., and Tokuhisa, T. (1998) A physiologic role of Bcl-xL induced in activated macrophages. J. Immunol. 160, 2590-2596
45. Chodakewitz, J. A., Lacy, J., Edwards, S. E., Birchall, N., and Coleman, D. L. (1990) Macrophage colony-stimulating factor production by murine and human keratinocytes. Enhancement by bacterial lipopolysaccharide. J. Immunol. 144, 2190-2196
46. Fixe, P., Rougier, F., Ostyn, E., Gachard, N., Faucher, J. L., Praloran, V., and Denizot, Y. (1997) Spontaneous and inducible production of macrophage colony-stimulating factor by human bone marrow stromal cells. Eur. Cytokine Netw. 8, 91-95
47. Lee, P. S., Wang, Y., Dominguez, M. G., Yeung, Y. G., Murphy, M. A., Bowtell, D. D., and Stanley, E. R. (1999) The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J. 18, 3616-3628
48. Carlberg, K., Tapley, P., Haystead, C., and Rohrschneider, L. (1991) The role of kinase activity and the kinase insert region in ligand-induced internalization and degradation of the c-fms protein. EMBO J. 10, 877-883
49. Myles, G. M., Brandt, C. S., Carlberg, K., and Rohrschneider, L. R. (1994) Tyrosine 569 in the c-Fms juxtamembrane domain is essential for kinase activity and macrophage colony-stimulating factor-dependent internalization. Mol. Cell. Biol. 14, 4843-4854
50. Downing, J. R., Roussel, M. F., and Sherr, C. J. (1989) Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms. Mol. Cell. Biol. 9, 2890-2896
51. Uden, M., Morley, G. M., and Dibb, N. J. (1999) Evidence that downregulation of the M-CSF receptor is not dependent upon receptor kinase activity. Oncogene 18, 3846-3851
52. Guilbert, L. J., and Stanley, E. R. (1984) Modulation of receptors for the colony-stimulating factor, CSF-1, by bacterial lipopolysaccharide and CSF-1. J. Immunol. Methods 73, 17-28
53. Baccarini, M., Dello Sbarba, P., Buscher, D., Bartocci, A., and Stanley, E. R. (1992) IFN-gamma/lipopolysaccharide activation of macrophages is associated with protein kinase C-dependent down-modulation of the colony-stimulating factor-1 receptor. J. Immunol. 149, 2656-2661
54. Hamilton, J. A. (1997) CSF-I signal transduction: what is of functional significance? Immunol. Today 18, 313-317
55. Smith, J. L., Schaffner, A. E., Hofmeister, J. K., Hartman, M., Wei, G., Forsthoefel, D., Hume, D. A., and Ostrowski, M. C. (2000) ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. Mol. Cell. Biol. 20, 8026-8034
56. Kamdar, S. J., Chapoval, A. I., Phelps, J., Fuller, J. A., and Evans, R. (1996) Differential sensitivity of mouse mononuclear phagocytes to CSF-1 and LPS: the potential in vivo relevance of enhanced IL-6 gene expression. Cell. Immunol. 174, 165-172
57. Stewart, C. C., Lin, H. S., and Adles, C. (1975) Proliferation and colony-forming ability of peritoneal exudate cells in liquid culture. J. Exp. Med. 141, 1114-1132
58. Stewart, C. C., Riedy, M. C., and Stewart, S. J. (1994) Introduction: the proliferation and differentiation of macrophages. Immunol. Ser. 60, 3-27
59. Chen, B. D., and Clark, C. R. (1986) Interleukin 3 (IL 3) regulates the in vitro proliferation of both blood monocytes and peritoneal exudate macrophages: synergism between a macrophage lineage-specific colony-stimulating factor (CSF-1) and IL 3. J. Immunol. 137, 563-570
60. Chan, J., Leenen, P. J., Bertoncello, I., Nishikawa, S. I., and Hamilton, J. A. (1998) Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. Blood 92, 1423-1431
61. Wiktor-Jedrzejczak, W., and Gordon, S. (1996) Cytokine regulation of the macrophage (M phi) system studied using the colony stimulating factor-1-deficient op/op mouse. Physiol. Rev. 76, 927-947
62. Lenda, D. M., Kikawada, E., Stanley, E. R., and Kelley, V. R. (2003) Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J. Immunol. 170, 3254-3262
63. Klebl, F. H., Olsen, J. E., Jain, S., and Doe, W. F. (2001) Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine. J. Pathol. 195, 609-615
64. Utsunomiya, Y., Omura, K., Yokoo, T., Imasawa, T., Kawamura, T., Abe, A., Hirano, K., Mitarai, T., Maruyama, N., and Sakai, O. (1996) Macrophage-colony stimulating factor (M-CSF) enhances proteinuria and recruitment of macrophages into the glomerulus in experimental murine nephritis. Clin. Exp. Immunol. 106, 286-296
65. Isbel, N. M., Nikolic-Paterson, D. J., Hill, P. A., Dowling, J., and Atkins, R. C. (2001) Local macrophage proliferation correlates with increased renal M-CSF expression in human glomerulonephritis. Nephrol. Dial Transplant 16, 1638-1647
66. Smith, J. D., Trogan, E., Ginsberg, M., Grigaux, C., Tian, J., and Miyata, M. (1995) Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. U. S. A. 92, 8264-8268
67. Kacinski, B. M., Scata, K. A., Carter, D., Yee, L. D., Sapi, E., King, B. L., Chambers, S. K., Jones, M. A., Pirro, M. H., Stanley, E. R., et al. (1991) FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 6, 941-952
68. Wing, E. J., Magee, D. M., Pearson, A. C., Waheed, A., and Shadduck, R. K. (1986) Peritoneal macrophages exposed to purified macrophage colony-stimulating factor (M-CSF) suppress mitogen- and antigen-stimulated lymphocyte proliferation. J. Immunol. 137, 2768-2773
69. Doyle, A. G., Halliday, W. J., Barnett, C. J., Dunn, T. L., and Hume, D. A. (1992) Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice. Infect. Immun. 60, 1465-1472
70. Wang, H., Cheng, F., Cuenca, A., Horna, P., Zheng, Z., Bhalla, K., and Sotomayor, E. M. (2005) Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance. Blood 105, 1135-1143
71. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., and Akira, S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745
72. Krieg, A. M., and Davis, H. L. (2001) Enhancing vaccines with immune stimulatory CpG DNA. Curr. Opin. Mol. Ther. 3, 15-24
73. Agrawal, S., and Kandimalla, E. R. (2002) Medicinal chemistry and therapeutic potential of CpG DNA. Trends Mol. Med. 8, 114-121
74. Paul, S. (2003) Technology evaluation: CpG-7909, Coley. Curr. Opin. Mol. Ther. 5, 553-559
75. Buchdunger, E., Cioffi, C. L., Law, N., Stover, D., Ohno-Jones, S., Druker, B. J., and Lydon, N. B. (2000) Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther. 295, 139-145
76. Arora, A., and Scholar, E. M. (2005) Role of tyrosine kinase inhibitors in cancer therapy. J. Pharmacol. Exp. Ther. 315, 971-979
77. Balabanov, S., Appel, S., Kanz, L., Brossart, P., and Brummendorf, T. H. (2005) Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells. Ann. N. Y. Acad. Sci. 1044, 168-177
78. Dietz, A. B., Souan, L., Knutson, G. J., Bulur, P. A., Litzow, M. R., and Vuk-Pavlovic, S. (2004) Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. Blood 104, 1094-1099
79. Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577-580
80. Hirota, S., Ohashi, A., Nishida, T., Isozaki, K., Kinoshita, K., Shinomura, Y., and Kitamura, Y. (2003) Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology 125, 660-667
81. Carter, T. A., Wodicka, L. M., Shah, N. P., Velasco, A. M., Fabian, M. A., Treiber, D. K., Milanov, Z. V., Atteridge, C. E., Biggs, W. H., 3rd, Edeen, et al. (2005) Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. Proc. Natl. Acad. Sci. U. S. A. 102, 11011-11016
82. Roth, P., Bartocci, A., and Stanley, E. R. (1997) Lipopolysaccharide induces synthesis of mouse colony-stimulating factor-1 in vivo. J. Immunol. 158, 3874-3880